tob2 (Santa Cruz Biotechnology)
Santa Cruz Biotechnology is a verified supplier 
92
Structured Review
Santa Cruz Biotechnology
tob2
Tob2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tob2/TOB2+Antibody/pm38801943-275-26-30
Average 92 stars, based on 9 article reviews
Tob2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tob2/TOB2+Antibody/pm38801943-275-26-30
Average 92 stars, based on 9 article reviews
tob2 - by Bioz Stars,
2026-09
92/100 stars
Images
Related Articles
Bioprocessing:Article Title: Expression of TOB/BTG family members in patients with inflammatory bowel disease. Article Snippet: This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record.. Please cite this article as doi: 10.1111/SJI.13004 This article is protected by copyright.. All rights reserved DR. JANETTE FURUZAWA-CARBALLEDA (Orcid ID : 0000-0001-5804-7221) PROF. JESUS YAMAMOTO-FURUSHO (Orcid ID : 0000-0002-5247-5812) Article Title: Differential expression of TOB/BTG family members in patients with plaque psoriasis: cross-sectional study. Article Snippet: TOB/BTG is a family of antiproliferative proteins that play an important role in the regulation of immune responses, acting as lymphocyte activators and macrophage-mediated cytotoxicity.. No previous studies have explored their role in patients with psoriasis.. The aim of this study was to characterize the expression of TOB/BTG family and their co-localization in skin from patients with psoriasis. Incubation:Article Title: TOB1 and TOB2 mark distinct RNA processing granules in differentiating lens fiber cells Article Snippet: .. Sections were incubated for 30 minutes at room temperature (RT) in blocking buffer (3% horse serum in PBS supplemented with 0.1% BSA) prior to incubation overnight with primary antibodies to TOB1 (1:200, mouse monoclonal, SC-133095, Santa Cruz Biotechnology, Dallas, TX, USA), Article Title: TOB1 and TOB2 mark distinct RNA processing granules in differentiating lens fiber cells. Article Snippet: .. Sections were incubated for 30 min at room temperature (RT) in blocking buffer (3% horse serum in PBS supplemented with 0.1% BSA) prior to incubation overnight with primary antibodies to TOB1 (1:200, mouse monoclonal, SC-133,095, Santa Cruz Biotechnology, Dallas, TX, USA), Article Title: Circulating miRNA-4701-3p as a predictive biomarker of cardiovascular disease which induces angiogenesis by inhibition of TOB2. Article Snippet: Angiogenesis is mainly regulated by the delivery of VEGF-dependent signaling to cells.. However, the angiogenesis mechanism regulated by VEGF-induced miRNA is still not understood.. After VEGF treatment in HUVECs, we screened the changed miRNAs through small-RNA sequencing and found VEGF-induced miR-4701-3p. Blocking Assay:Article Title: TOB1 and TOB2 mark distinct RNA processing granules in differentiating lens fiber cells Article Snippet: .. Sections were incubated for 30 minutes at room temperature (RT) in blocking buffer (3% horse serum in PBS supplemented with 0.1% BSA) prior to incubation overnight with primary antibodies to TOB1 (1:200, mouse monoclonal, SC-133095, Santa Cruz Biotechnology, Dallas, TX, USA), Article Title: TOB1 and TOB2 mark distinct RNA processing granules in differentiating lens fiber cells. Article Snippet: .. Sections were incubated for 30 min at room temperature (RT) in blocking buffer (3% horse serum in PBS supplemented with 0.1% BSA) prior to incubation overnight with primary antibodies to TOB1 (1:200, mouse monoclonal, SC-133,095, Santa Cruz Biotechnology, Dallas, TX, USA), Membrane:Article Title: Circulating miRNA-4701-3p as a predictive biomarker of cardiovascular disease which induces angiogenesis by inhibition of TOB2. Article Snippet: Angiogenesis is mainly regulated by the delivery of VEGF-dependent signaling to cells.. However, the angiogenesis mechanism regulated by VEGF-induced miRNA is still not understood.. After VEGF treatment in HUVECs, we screened the changed miRNAs through small-RNA sequencing and found VEGF-induced miR-4701-3p. Saline:Article Title: Circulating miRNA-4701-3p as a predictive biomarker of cardiovascular disease which induces angiogenesis by inhibition of TOB2. Article Snippet: Angiogenesis is mainly regulated by the delivery of VEGF-dependent signaling to cells.. However, the angiogenesis mechanism regulated by VEGF-induced miRNA is still not understood.. After VEGF treatment in HUVECs, we screened the changed miRNAs through small-RNA sequencing and found VEGF-induced miR-4701-3p. other:Article Title: Tob2 Inhibits Peroxisome Proliferator-Activated Receptor ?2 Expression by Sequestering Smads and C/EBP? during Adipocyte Differentiation Article Snippet: The following antibodies were used: Tob2 (polyclonal antibody; as described in reference 1 ), Tob (mouse monoclonal antibody; as described in reference 45 ), ANA/BTG3 (polyclonal antibody; as described in reference 57 ), |